five

In-silico structural studies on anti-inflammatory activity of phytocompounds from the genus Andrographis

收藏
Figshare2023-07-13 更新2026-04-28 收录
下载链接:
https://figshare.com/articles/dataset/_i_In-silico_i_structural_studies_on_anti-inflammatory_activity_of_phytocompounds_from_the_genus_Andrographis/23677522
下载链接
链接失效反馈
官方服务:
资源简介:
Plant species from the genus Andrographis were used in Ayurveda and in other folklore medicines for treating ailments for centuries. In this study, we have hypothesized to evaluate the secondary metabolites as potent anti-inflammatory agents from the genus Andrographis. A library of secondary metabolites of the said genus was curated from the PubChem database and was subjected to energy minimization using UCSF Chimera software employing the AMBER force field. Initially, molecular docking was performed to evaluate the binding affinity of the curated library against the enzymes cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and 5-Lipoxygenase (5-LOX) using AutoDock Vina. This resulted in shortlisting of two metabolites Echioidinin 5-O-glucoside was bound and 5,2',6'-Trihydroxy-6,7,8-trimethoxy flavone 2'-O-glucoside with high binding affinity than standard drugs Ibuprofen and Zileuton. In addition, molecular dynamic simulation studies confirm that these compounds form relatively more stable complexes than standard drugs with the above-said enzymes. The free binding energy values using MMGBSA of the above said ligands with COX-1, COX-2, and 5-LOX were found to be −49.18 kcal/mol, −38.60 kcal/mol, and −54.27 kcal/mol respectively, Whereas the standards have −21.77 kcal/mol, −9.96 kcal/mol, and −10.29 kcal/mol. Moreover, the in-silico ADMET analysis confirms the druggability of the shortlisted compounds. Later, this work will act as a base for in-vitro and in-vivo experimental studies to validate the anti-inflammatory potential of the same. Communicated by Ramaswamy H. Sarma
创建时间:
2023-07-13
5,000+
优质数据集
54 个
任务类型
进入经典数据集
二维码
社区交流群

面向社区/商业的数据集话题

二维码
科研交流群

面向高校/科研机构的开源数据集话题

数据驱动未来

携手共赢发展

商业合作